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The influence of early-phase remodeling events on
the biomechanical properties of engineered
vascular tissues
Zehra Tosun,a Carolina Villegas-Montoya, MS,b and Peter S. McFetridge, PhD,a Gainesville, Fla; and
Norman, Okla
Objectives: During the last decade, the use of ex vivo–derived materials designed as implant scaffolds has increased
significantly. This is particularly so in the area of regenerative medicine, or tissue engineering, where the natural chemical
and biomechanical properties have been shown to be advantageous. By focusing on detailed events that occur during
early-phase remodeling processes, our objective was to detail progressive changes in graft biomechanics to further our
understanding of these processes.
Methods: A perfusion bioreactor system and acellular human umbilical veins were used as a model three-dimensional
vascular scaffold on which human myofibroblasts were seeded and cultured under static or defined pulsatile conditions.
Cell function in relation to graft mechanical properties was assessed.
Results: Cells doubled in density from approximately 1  106 to 2  0.4  106 cells/cm ringlet, whereas static cultures
remained unchanged. The material’s compressive stiffness and ultimate tensile strength remained unchanged in both
static and dynamic systems. However the Young’s modulus values increased significantly in the physiologic range,
whereas in the failure range, a significant reduction (66%) was shown under dynamic conditions.
Conclusions: As pulse and flow conditions are modulated, complex mechanical changes are occurring that modify the
elastic modulus differentially in both physiologic and failure ranges. Mechanical properties play an important role in graft
patency, and a dynamic relationship between structure and function occurs during graft remodeling. These investigations
have shown that as cells migrate into this ex vivo scaffold model, significant variation in material elasticity occurs that may
have important implications in our understanding of early-stage vascular remodeling events. ( J Vasc Surg 2011;54:
1451-60.)
Clinical Relevance: Engineering vessels that possess biomechanical properties are similar to natural arteries is an
important research objective. Although we are beginning to understand the complex nature of tissue remodeling, little is
currently known for how these early remodeling events influence the mechanical behavior of these tissues. These
investigations characterized biomechanical changes that occur during early-phase remodeling events and compared the
variation as a function of dynamic stimulation within an acellular human umbilical vein scaffold. Our findings showed
that early remodeling events of these in vitro-engineered blood vessels have a significant effect on graft elasticity. These
mechanical changes occur independently of ultimate tensile strength, suggesting early biomechanical changes may be an
important marker for successful adaptation of engineered blood vessels.
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eSmall-diameter vascular bypass graft materials (6 mm)
have high failure rates due predominantly to poor biologic
interactions and functionality.1,2 Tissue engineering or de
novo regeneration of small-diameter blood vessels has
shown significant promise to develop biologically func-
tional alternatives as vascular replacements.3,4 Significant
progress has been made with this approach from the pio-
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doi:10.1016/j.jvs.2011.05.050eering 1986 work of Weinberg and Bell5 using natural
ydrogels to later examples designed with synthetic mate-
ials6,7 and acellular grafts.8,9
Although the potential has been shown with reduced
hrombogenicity and enhanced patency rates, further prog-
ess is needed to provide a routine, clinically viable solu-
ion.10,11 Of the many candidate materials researched, nat-
rally occurring ex vivo matrices, or polymer derivatives
uch as collagen or fibronectin, aim to take advantage of
ative tissue mechanics and biologic moieties that enhance
iologic function and integration.12-16
An important goal has been to engineer vascular
rafts with mechanical properties similar to natural ves-
els, and a significant amount of research has been con-
ucted to assess culture systems and environmental con-
itions that may improve graft performance. To
ecapitulate, these conditions, bioreactors, and perfusion
ow systems aim to emulate the in vivo environment to
nhance tissue regeneration by modulating cellular phe-1451
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November 20111452 Tosun et alnotype and improving mass-transport limitations and
long-term sterility.17-20
Using a pulsed perfusion bioreactor, Hoerstrup et al21
designed systems that have shown that constructs cultured
for 1 month resulted in significant improvements of burst
strength, from 50 mm Hg for static controls to 326 mm
Hg for conditioned samples. Using a different approach,
L’Heureux et al22 developed a well-defined three-layered
vessel structure by adding concentric layers of cellular
sheets that, after 12 weeks of preparation and culture,
displayed burst strength 2000 mm Hg. More recently,
Syedain et al23 investigated the effects of circumferential
strain amplitude, ranging from 2.5% to 20% either con-
stantly or incrementally, to evaluate the effects on fibrin
remodeling. The incremental circumferential strain re-
sulted in a 50% increase in ultimate tensile strength of
2295  467 kPa compared with constant circumferential
stress, showing the complex nature of vessel remodeling
and adaptation during regenerative processes.23
Although we are beginning to understand the complex
nature of tissue remodeling and the broad effects of me-
chanical stimulation, little is currently known of how these
early remodeling events influence the biomechanical be-
havior of these developing tissues. Extracellular matrix
(ECM) remodeling, and the factors that influence the
remodeling process, are important and require more de-
tailed investigation, particularly so with tissue-based mate-
rials where the primary ECM macromolecules provide the
bulk of the structural support.
Since the late 1970s, the human umbilical vein (HUV)
has been used as a glutaraldehyde cross-linked allograft that
has shown improvements in graft patency compared with
many synthetic materials.24 Similar to other aldehyde-
Fig 1. In the dynamic cell culture setup, three bioreacto
and abluminal flow circuits, with their respective me
Decellularized human umbilical vein samples were seedetreated materials, the cross-linking process used on current Alinical versions of this material inhibits cell migration and
ubsequent remodeling because the cells are not able to
egrade these induced bonds.
In 2005 Daniel et al9 developed an automated method
o rapidly and uniformly dissect the HUV directly from
mbilical cord. We used this automated dissection proce-
ure to decellularize the HUV scaffold to form an acellular
caffold without artificially induced stabilization such as
ormaldehyde or glutaraldehyde treatments. The perceived
dvantage of this approach is a reduced immune response
hat allows adhered cells (seeded in vitro or naturally in
ivo) to positively remodel the scaffold without the inflam-
atory response rapidly degrading the tissue, which would
therwise lead to graft dilation and possible aneurysm
ormation. As such, remodeling can occur in a more stable
ashion, leading to a fully cellular and functional graft.
These investigations used the HUV model system to
valuate blood vessel regeneration. The goal of our exper-
mental design was to characterize biomechanical changes
hat occur during early-phase cellular remodeling events
ith the HUV, when prepared as a nonstabilized graft, and
ompare the variation as a function of dynamic stimulation.
o assess these early regenerative events, two independent
onditions were evaluated: (1) static culture and (2) dy-
amic perfusion culture. Three sets of perfusion bioreactors
ere connected in series with independent lumen and
bluminal flow circuits to control perfusion condition.
onstructs were cultured to assess changes in construct
iomechanics and cellular activity as a function of culture
echnique and time.
ATERIAL AND METHODS
Cell culture. Human myofibroblasts (CRL-2854;
B, andC) were connected in series and included luminal
reservoirs (D and E) and rotary pumps (G and F).
h myofibroblasts and cultured for 21 days.rs (A,
diumTCC, Manassas, Va) and cultured in high glucose (4.5
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Volume 54, Number 5 Tosun et al 1453g/L) Dulbecco’s modified Eagle’s medium (Invitrogen,
Carlsbad, Calif), supplemented with 10% fetal bovine se-
rum, 1% L-glutamine, and 1% penicillin streptomycin (In-
vitrogen) with 5% CO2 at 37°C. Cells were prepared for
seeding when at 60% to 70% confluence at passage six.
Scaffold preparation and bioreactor assembly.
Veins were dissected from the cord as described previously,25
cut to 110-mm lengths and agitated for 24 hours in 1%Triton
X-100 on an orbital shaker. Vessels were rinsed in distilled
water for 10 minutes, followed by 20-minute, 1-hour, and
24-hour washes, and incubated in 70 U/mL DNase in PBS
supplementedwithMg2 (Sigma-Aldrich Inc, St. Louis,Mo)
for 3 hours at 37°C, then rinsed.
As shown in Fig 1, HUV segments were loaded in the
perfusion bioreactors (three in series) with each scaffold taken
from a different placental origin. Three bioreactors (Fig 1,
A-C) were connected in series, with two independent flow
Fig 2. Hydrogel contraction is shown around the hu
hydrogel contracting from the bioreactor glass wall and
the bioreactor void space. B, After 5 hours of gel reac
bioreactor wall. C, Themediumwas initially perfused aro
D, After the selected intervals, the vascular constructs wcircuits (luminal and abluminal surface), each with respective Aedia reservoirs (Fig 1,D and E) and rotary pumps (Fig 1,G
nd F).
Samples were sterilized using 0.2% peracetic acid and 4%
thanol, circulated through the lumen and abluminal sides for
hours, pH-balanced with multiple washes of PBS, and
retreated overnight with complete growth media.
Seeding protocol. Cells were seeded to the abluminal
urface of the HUV scaffold using a hydrogel contraction
echnique developed in our laboratories. Briefly, human
yofibroblasts were suspended in 1.9 mg/mL type 1 col-
agen gels (Purcol, Inamed, Fremont, Calif) containing 1
06 cells/mL and inoculated into the abluminal void
pace of the bioreactors surrounding the scaffold (10 mL/
caffold). Bioreactors were placed in a 0% CO2 incubator
or 5 hours at 37°C for gel polymerization. After the initial
el contraction, the culturemediumwas circulated through
he abluminal void space at a flow rate of 1.5 mL/min.
umbilical vein (HUV) cell scaffold. The sequence of
d the HUV is shown. A, The hydrogel was loaded into
the collagen had polymerized and detached from the
he void space and circulated freely on the abluminal side.
moved from the bioreactors and characterized.man
aroun
tion,
und tfter 48 hours, lumen flow was slowly ramped in incre-
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November 20111454 Tosun et alments of 2.5 mL/min every 2 hours until 10 mL/min was
reached, at which point abluminal flow was increased to 2
mL/min. During the next 4 days, the luminal flow rate was
increased in increments of 10 mL/min each day to a
maximum of 50 mL/min (90 beats/min). Samples cul-
tured under static conditions were seeded as above and
then placed in T-75 culture flasks and maintained. After 7
and 21 days, the vascular constructs were removed from the
bioreactors, and characterized (Fig 2, A-D).
Construct characterization. Samples were collected
from the proximal, middle and distal positions (three each,
for a total of nine discrete samples per condition) of each
construct and were analyzed for cellularity and cell migra-
Fig 3. Static and dynamic constructs thicknesses are shown. The
initial average value for the wall thickness is represented with the
dashed line. Dynamic cultured constructs exhibited reduced thick-
ness from the static samples, as well as from the initial thickness
value. The error bars show the standard deviation.
Fig 4. A, Cell density and (B) metabolic activity of constructs
cultured under dynamic and static conditions over 7 and 21 days.
The error bars show the standard deviation.tion using standard histologic techniques, as follows: oellular metabolic activity was assayed using the non-
toxic redox indicator dye Alamar blue (BioSource
International Inc, Camarillo, Calif). Alamar blue re-
agent was added to the sample media (10% dilution)
and incubated at 37°C for 6 hours and then analyzed
using a Synergy HT plate 15 reader (Bio-Tek, Win-
ooski, Vt) to measure the absorbance shift from 570
to 600 nm. Double-stranded DNA (dsDNA) con-
centration was assessed to determine cell density
using the Pico Green assay (Invitrogen). Pico Green
is a fluorescent nucleic acid stain that binds dsDNA
in a stoichiometric ratio and is used to quantify
dsDNA at excitation and emission wavelengths of
485 and 535 nm. Calibration curves were produced
for known concentrations of cells to DNA that were
then used to determine the DNA concentration/cell.
Cellular metabolic activity was normalized against
cell density, where the total metabolic activity of each
sample was divided into the cell number.
amples for histologic analysis were fixed in 3% formalde-
hyde in PBS, dehydrated, embedded in paraffin blocks,
and sectioned at 6 m. Sections were stained with
hematoxylin and eosin and viewed using a Nikon,
Eclipse E800 epifluorescent microscope (Nikon, Mel-
ville, NY). Cell migration was measured from multiple
histology images using ImageJ software (National In-
stitutes of Health, Bethesda, Md). The degree of cell
migration was assessed from the abluminal surface to
the cell location at each specific time point. Nine mea-
surements were taken from within each section and
averaged to quantify the average migration for each
sample set.
Tensile and cyclic compressive testing. All samples
ere maintained in complete cell culture media until anal-
sis 30 minutes of bioreactor disassembly. Mechanical
nalysis was conducted using a uniaxial tensile testing rig
Instron 5542, Norwood, Mass). For tensile analysis, scaf-
olds were cut into 5-mm-wide ringlets. Tissue specimens
n  9) were loaded using stainless steel L-shaped hooks.
amples were preloaded to a stress of 0.005 N at a rate of 5
m/min and then elongated until failure, with force and
xtension recorded over time. To assess the elastic behavior
f the vessel wall, material properties were identified over
wo regions: a low-strain region that reflects physiologic
ehavior (physiologic range), and a high-strain region
failure range) where collagen fibers are extended by
ncreasing stress levels until failure.26 The low-strain
egion representing physiologic pressure conditions
ere set from 0.01 MPa (80 mm Hg) to a maximum of
.02 MPa (120 mm Hg).
Material stiffness was calculated from the stress strain
ata to derive the Young’s modulus over these two
ones. The slope of the linear region before failure was
sed to calculate the Young’s modulus measure of ma-
erial stiffness. The ultimate tensile strength (UTS) was
btained from the stress–strain graph, corresponding to
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rupture.
Samples prepared for compression analysis were ob-
tained by longitudinally sectioning the vessels, and a circu-
lar stainless steel punch was used to remove 0.79-mm outer
diameter disks from samples (n  9). Disks were fixed to
the lower compression plate and hydrated with PBS. Uni-
axial cyclic compression tests were conducted such that the
compression vector was perpendicular to the vessel wall.
Our investigations assessed the effect of physiologically
relevant applied compressive strain (10%) to determine
cyclic compressive properties of the constructs.27 Indenter
displacement was set to 0.02 mm/s, and samples were
compressed to amaximum strain of 10%. The load was then
progressively released at the same rate to 0% strain, for a
total of 15 cycles.
The load-vs-displacement data were collected and con-
verted to stress and strain. The maximum value of the
Fig 5. Histologic images are shown for (top row) sta
umbilical vein constructs (hematoxylin and eosin stain). C
at a lower density relative to dynamic cultures, with cells
an increase in cell concentration, both in unit area and ocompressive stiffness was derived from the maximum slope af the stress-vs-strain response (up to 10% strain) during
ompression loading. Energy dissipation per unit volume
as calculated from the hysteresis data for each construct.
ean values of energy dissipation per unit volume in the
nal compression cycle were compared with the initial cycle
nd calculated as a percentage.
Statistical analysis. All analyses were done in tripli-
ate, unless otherwise stated. From each of the three con-
tructs comprising the triplicate set, a further three samples
ere analyzed, obtaining a total of nine data points for each
ondition. A multicomparison Tukey test by one-way anal-
sis of variance (P  .05) was used to determine statistical
ignificance. All data are presented as the mean  standard
eviation.
ESULTS
Construct thickness. Construct thickness was mea-
ured in the proximal, middle, and distal positions. The
y and (bottom row) dynamically conditioned human
ultured under static conditions were more dispersed and
rating up to 200 m. Dynamic conditioning resulted in
total density.ticall
ells c
penetverage is presented in Fig 3. Constructs exposed to dy-
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November 20111456 Tosun et alnamic culture conditions for 7 and 21 days displayed a
decrease in wall thickness relative to static culture con-
structs and acellular static controls. The wall thickness of
constructs cultured under static conditions and acellular
controls did not show any significant change. The initial
average value for the wall thickness was 1.8 mm. Dynamic
conditioned constructs at day 7 had an average wall thick-
ness of 1.08  0.04 mm, whereas static cultures yielded
1.72  0.3 mm. At day 21, dynamic wall thickness was
1.28  0.15 mm and static was 1.6  0.19 mm.
Cell density. After 7 days, no significant difference
was detected in cellularity between dynamic and static
constructs (P  .579). However, in response to dynamic
stimulation for 21 days, cell growth increased significantly
from 0.99 to 1.94 0.47 106 cells/10-mm ringlet (P
.003) as seen in Fig 4, A.
Cellular metabolic activity. AB reduction was as-
sessed to evaluate the metabolic activity of cells adhered to
the scaffold. Data for gross metabolic activity were com-
bined with quantitative cell density and expressed as the
percentage of AB reduction per cell (Fig 4, B). HUV
constructs cultured under dynamic stimulation conditions
within the bioreactors displayed a significant increase in
metabolic activity vs static samples at 7 and 21 days. How-
ever, the culture time had no significant effect on activity:
similar values were found for both culture methods at
day 21.
Histologic analysis. Cell migration and location
within the HUV constructs are displayed in Fig 5; showing
that distribution within the HUV was strongly dependent
on the culture approach. After 7 days of dynamic culture,
cells formed continuous interconnected layers cells around
the periphery of the scaffold, with infiltration up to 44 11
m. By contrast, after 21 days of perfusion flow condition-
ing, cells displayed increased cellular in-growth and mi-
grated into the scaffold up to 101  20 m, forming
clusters of increased cell density embedded within the
matrix pores. The overall structure of the HUV was largely
retained, showing a defined circularly disposed tunica me-
dia, followed by a layer with less packed collagen fibers or
adventitia leading to an outer layer corresponding to the
Wharton’s jelly material from the umbilical cord. Samples
exposed to dynamic culture had a reduced wall thickness,
displaying a more compressed structure (Fig 3 and Fig 5).
Tensile analysis. No statistical difference in UTS was
noted between the two culture conditions at 21 days (P 
.703); however, values were lower than acellular controls at
450 kPa. The construct UTS for static and dynamic cul-
tures were, respectively, 220 60 and 140 20 kPa at day
7, 80  60 and 180  40 kPa at day 21 (Fig 6).
Mechanical stiffness (tissue elasticity) in the low-strain
region of the dynamically stimulated constructs increased
from 450  140 to 550  190 kPa during the culture
period. By 21 days, the static and dynamic scaffolds both
had statistically similar values, showing an increase in stiff-
ness relative to acellular controls. By contrast, the elasticity
of dynamically conditioned constructs in the failure range
increased 66% from 610  210 kPa at day 7 to 200  110 cPa at day 21. The Young’s modulus of the static cultures
emained constant at 550  60 kPa for day 7 and 790 
80 kPa for day 21 (Fig 7).
Construct elongation, expressed as the tensile strain (%)
nd tensile strain at max load, was calculated at physiologic
ange and failure range. Fig 7 shows the physiologic range
ith a max stress value of 120 mmHg (0.02 MPa) and the
ailure range before failure. Over the physiologic range, the
tatically cultured constructs displayed increased strain val-
es compared with dynamic constructs. In the failure
ange, constructs exposed to dynamic conditioning had a
ignificant increase in strain value from day 7 (82% 
0.5%) to day 21 (227%  59.5%). Static constructs re-
ained unchanged.
Compression analysis. A representative stress–strain
esponse curve for samples under compressive loading is
hown in Fig 8, A. The response of the material to cyclic
ompression displayed the characteristic soft tissue hyster-
sis associated with energy dissipation as the cyclic stress is
eleased. For both groups, dynamic and static, the tissue
esistance to compression and energy dissipation was the
ighest during the first compressive cycle and then de-
reased in subsequent cycles. The mean values of peak
ysteresis (kJ/m3) in the final compression cycle were
ompared with the initial cycle. Data show energy dissipa-
ion after the first cycle and in subsequent cycles reduced up
o 90% of the original value by the 15th cycle (Fig 8, B).
nly dynamically stimulated constructs at day 21 showed a
tatistically significant reduction compared with the other
ig 6. Mechanical properties of constructs were evaluated at 7
nd 21 days in culture. No significant difference in the ultimate
ensile strength was found between statically and dynamically
onditioned vascular constructs (P  .05) using one-way analysis
f variance. The dashed line denotes the acellular human umbilical
ein control. The error bars show the standard deviation.onstructs.
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the first cycle at day 7 was not significantly different than at
day 21 for both culture conditions. Similarly, the response
to the last compressive cycle was unchanged over the 21-
day period (Fig 9). The compressive stiffness was calculated
from the stress–strain curves as the maximum slope of the
compressive stress–strain graph in the first cycle remained
unchanged from day 7 to 21 under both dynamic and static
conditions (Fig 9). At day 21, constructs had a compressive
modulus of 20.7  7.0 kPa under static conditions and
23.3  8.0 kPa for dynamic conditions.
DISCUSSION
A critical, yet poorly understood, aspect of the remod-
eling processes is the biomechanical transformation that
occurs throughout the regenerative process. Graft failure
can be predicted when material mechanical properties are
mismatched to the host vasculature at the implantation site,
and as such, is a critical parameter to assess.28,29 From this
perspective, ex vivo–based materials have an advantage
over currently used synthetic conduits that are typically
stiffer and less compliant than native vessels. The body’s
natural remodeling machinery progressively modifies the
Fig 7. Comparison is shown of Young’s modulus and ten
and (right) the failure range. Dynamic culture resulted
remained unchanged under static culture. After 21 day
compared with the static group (P .05). The dashed line
bars show the standard deviation.ECM of ex vivo materials through balanced degradative ind synthetic pathways that alter the tissues’ mechanical
roperties over time. A balance between ECM synthesis
nd degradation is clearly a critical factor, particularly
ith arterial grafts, where ECM failure may have fatal
onsequences.
In these investigations, human myofibroblasts were
eeded onto an ex vivo–based acellular scaffold and
ultured under dynamic perfusion conditions to assess
road biologic phenomena in concert with biomechanical
hanges. Our goal in assessing these properties was to
urther our understanding of how in vitro culture influ-
nces graft mechanics during early-phase remodeling
vents.
A number of in vitro studies by other groups have
emonstrated the effects of mechanical stimulation and the
irect effects on accelerated cell proliferation, extracellular
atrix production, and vascular remodeling.30-32 Our in-
estigations confirm this broad trend: constructs cultured
nder dynamic conditions had higher metabolic activity
nd cellularity than comparative constructs cultured under
tatic conditions. Similarly, Stegemann and Nerem30
howed that embedding smooth muscle cells in three-
imensional collagen scaffolds, without mechanical load-
train at maximum stress over (left) the physiologic range
re elastic constructs after day 21, whereas this property
e dynamic culture group presented decreased stiffness
tes the acellular human umbilical vein control. The errorsile s
in mo
s, th
denong, led to decreased cellular proliferation and -actin ex-
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November 20111458 Tosun et alpression relative to monolayer cultures. Cells subjected to a
low-load environment (ie, floating collagen matrix) were
inclined to become quiescent over time, and as themechan-
ical load was increased, fibroblasts displayed higher prolif-
eration rates, matrix synthesis, and -actin fiber formation.
Mechanical stimulation generally benefits construct
properties; however, extended culture times in vitro may
not result in beneficial remodeling. The investigations by
Seliktar et al33 showed that although mechanically stimu-
lated collagen constructs seeded with human aortic SMCs
displayed enhanced ultimate tensile stress and increased
stiffness values over shorter culture periods (4 days), con-
structs subjected to prolonged mechanical stimulation (8
days) deteriorated. These findings led them to suggest that
the variation in collagen compaction and consequent me-
chanical properties is the result of a cell-mediated remod-
eling that is largely regulated by mechanical stimulation.33
Although their time points were reduced compared with
our study, there is some correlation with a change in
stiffness that may be attributed to a similar mechanism
where the balance between remodeling degradation and
synthesis may not always be in balance. This again demon-
strates the importance of mechanical and biochemical cues
that determine cell phenotype.30
A material’s compression characteristic is a physical prop-
erty that is often overlooked but provides a better understand-
ing of amaterial’s bulk properties beyondwhat tensile analysis
offers. Broadly, mechanical analysis can be put into two data
sets. The first is to compare amaterial’s behavior—in this case,
vascular tissue—with relevant physiologic conditions, and the
second is to understand how amaterial performs, as a discrete
material, regardless of its application. Tensile testing can rep-
resent “stretching or stress loading” of a tissue, and it also
Fig 8. A, Representative compressive stress–strain relationship is
shown for the human umbilical vein constructs under cyclic com-
pression. Dynamic samples displayed resistance to compression
from an applied strain of 5%. The hysteresis loops indicate that
energy is dissipated inside the disk when load is retrieved. B,
Percentage of energy dissipation is shown. The mean values of
hysteresis in the final compression cycle compared with the initial
cycle were plotted. The amount of energy dissipation in subse-
quent cycles was reduced to about 50% to 90% of the original value
after 15 cycles. The dashed line denotes acellular HUV control.
The error bars show the standard deviation.characterizes performance that allows others to compare wroperties to other materials. This is also the case with com-
ression analysis. Compressive stress is an important parame-
er of wall mechanics over the systolic/diastolic pressure
hange, as indicated by a thinning of the wall as pressure
ncreases.34 Again, although this is a useful physiologic attri-
ute to assess, it plays a significant role in a more fundamental
haracterization of the material’s properties that allows direct
omparison.
As part of this compressive testing, the energy dissipa-
ion was calculated to understand how these vascular grafts
often during cyclic loading as a function of how fluid is
queezed out during compression and how it returns as
ressure is released relative to the initial cyclic load. A
lower recovery (toward its initial condition) infers the
issue has become softer relative to a control sample.35 In
his study, for dynamically stimulated constructs at day 21,
t is interesting that although the scaffold’s elasticity in-
reased at failure range, the percentage reduction of energy
issipation showed a significant reduction, “therefore soft-
ning of these constructs.” No change was noted in the
TS and in compressive stiffness. This variation was only
oted in the failure range, with the Young’s modulus in the
hysiologic range remaining unchanged at day 21 with
ynamically cultured constructs.
Increased stiffness at low strain region may be attrib-
ted to partial fragmentation of elastin fibers that results
ith the increased contribution of collagen fibers.36 At the
igher strain values (failure range), a number of possibilities
ay explain the 66% decrease in stiffness but without any
ignificant change in the UTS. A partial degradation of the
onds that hold the larger collagen fibers together—but
ot of the actual fibrils—would largely maintain the ECM
trength but might decrease stiffness because molecules are
reer to slide against one another. This may be further
ttenuated by the outer Wharton’s jelly that consists largely
f glycosaminoglycans is remodeled with a higher (relative)
oncentration of collagen. This may maintain the UTS, but
ncreased stiffness results because the collagen has not fully
atured (low cross-link density).
In vivo graft dilatation may occur as early as the initial
daptation period, where overexpression of matrix metal-
oproteinases by vascular smooth muscle cells and inflam-
atory cells can result in the degradation of elastin and
ollagen.37 Weakening of the scaffold is expected to some
xtent during this early remodeling period because the
ewly synthesized and deposited ECM is in a less structured
rientation. It is then reorganized as the remodeling pro-
ess matures and is naturally cross-linked to enhance the
trength of the collagen fibers and ECM as a whole. How-
ver, a secondary mechanism may explain a partial ECM
eterioration that is more specific to acellular (ex vivo)
caffolds. The expressed matrix metalloproteinases, which
re typically associated closely with the cell membrane, are
ypothesized to have a more distant effect of ECM me-
hanics by freely diffusing through the acellular scaffold to
ore distant zones of the scaffold. Although there is no
irect evidence for this effect, this may explain an overall
eakening that might occur, especially if cell migration is
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possibilities.
Engineering vessels that possess similar biomechanical
properties to natural arteries is an important research ob-
jective. Scaffold remodeling, the key process in effective
regeneration, is a complex process that is clearly influenced
by multiple factors, including mechanical stimulation, scaf-
fold composition and structure, cell type, culture chemis-
try, and many other more subtle elements. Mismatch be-
tween graft and the host artery causes a variety of effects
that can produce an abnormal endothelial and smooth
muscle cell phenotype that results in pathologies, such as
thrombosis and intimal hyperplasia, which are primary
causes of graft failure.38,39 In this study, mechanical condi-
tioning was used to direct cell function, and biomechanical
properties of the tissue scaffold changed over time as a
result. Maintaining, or at least directing, the biomechanical
changes that occur during scaffold remodeling remain a
challenge.
CONCLUSIONS
These findings have shown that studying the HUV
Fig 9. Top, Maximum strength obtained during first a
difference was present between the peak strength at the
stiffness for the vascular constructs were obtained as the
significant difference was obtained between groups. In
umbilical vein control, and the error bars show the standbiomechanical properties of engineered blood vessels un- Ser conditions that broadly mimic in vivo mechanics is a
seful model to better understand in vitro remodeling
rocesses. Although some parallels can be drawn with in
ivo remodeling, these in vitro investigations, where single
ell populations can be assessed independently, are de-
igned to be more progressive in nature. As such, the
emodeling processes in vivo are considerably more com-
lex, with contributions by other cellular systems, includ-
ng the host immune response. Further optimization will
rovide insight into these more complex remodeling pro-
esses that may improve our understanding of heterolo-
ous transplant graft remodeling and also engineered vessel
egeneration.
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